Q&A Insights
Explore more insights from key opinion leaders in exclusive Q&As and written articles:
Dermatology Times is recapping our exclusive expert interviews from the month of November.
At Elevate-Derm Fall, Ted Rosen, MD, detailed how rapidly evolving resistance in bacteria, fungi, viruses, and more is reshaping therapeutic choices.
Discover how Prithwiraj Maitra, PhD, advances skin care innovation with exosomes, emphasizing scientific validation and ingredient transparency in cosmetic formulations.
Allergan Aesthetics pioneers regenerative skincare through secretome science, enhancing skin health with fibroblast-derived exosomes for transformative results.
Discover the latest advancements in botulinum toxins, including TrenibotE's rapid effects and onabotulinumtoxinA's consistent results for aesthetic treatments.
Shannon Trotter, DO, explores social media's impact on dermatology, lichenoid disorders, and granuloma annulare at SDPA Fall 2025.
Victoria Garcia-Albea, NP, outlined evolving therapeutic strategies at Elevate-Derm Fall, highlighting low-dose oral minoxidil, off-label JAK inhibition for frontal fibrosing alopecia, Thiamidol in hyperpigmentation, and delgocitinib for chronic hand eczema.
GLP-1 medications are reshaping dermatology, driving increased patient demand for treatments addressing facial volume loss and jowling concerns, according to Joely Kaufman, MD.
Using multiple treatment modalities often achieves superior repigmentation compared with monotherapy, according to Michael Lewitt, MD.
Explore more insights from key opinion leaders in exclusive Q&As and written articles:
New findings from LEO Pharma reveal chronic hand eczema affects 1 in 10 adults, highlighting the need for improved recognition and management in dermatology.
James Canner, PA-C, outlines key updates in acne therapeutics, alopecia management, and rheumatology–dermatology collaboration presented at Elevate-Derm Fall.
Marc Serota, MD, discusses using ruxolitinib cream to safely maintain repigmentation, minimize steroid-related adverse effects, and enhance outcomes when combined with phototherapy.
Yasmine Kirkorian, MD, shares insights on pediatric dermatology advancements and genetic skin disorders at SDPA Fall 2025, emphasizing early diagnosis and innovative therapies.
Harrison Nguyen, MD, shares groundbreaking insights on CSU, vasculitis, and bullous diseases at the SDPA Fall 2025 conference, enhancing dermatologic education.
At Elevate-Derm, Buchi Neita, PA-C, discussed treatment expectations for vitiligo, triple-combination cream for acne, early diagnosis in HS, and what she’s looking forward to in the 2026 pipeline.
Lindsay Ackerman, MD, explains the importance of transparency when prescribing medications with boxed warnings.
Explore how a groundbreaking initiative by Hayden Middleton, PA-C, bridges dermatology and nutrition, enhancing patient care and clinician fulfillment.
At Elevate-Derm Fall, sisters Shanna Miranti, MPAS, PA-C, and Larissa Schmidt, DPM, reviewed the benefits of cross-specialty collaboration for patient care.
Andrew Baker, MBA, MPAS, PA-C, discusses leadership and inclusivity in dermatology at the SDPA Fall Conference, emphasizing collaboration and member engagement for future growth.
Joseph Gatti, DMSc, MPAS, MBA, highlights the importance of collaboration between PAs and dermatologists, emphasizing mutual respect and the role of PAs in enhancing patient care.
At the Elevate-Derm Fall Conference, Peter Lio, MD, highlighted practical strategies for corticosteroid stewardship, the expanding role of nonsteroidal topicals, and emerging opportunities in early-age indications that are reshaping pediatric inflammatory dermatoses care.
At Elevate-Derm Fall, Patricia Delgado, DNP, AGPCNP, DCNP, PMHNP, outlined practical ways dermatology clinicians can incorporate psychodermatology principles and previewed the upcoming Psych and Skin video series.
Mondana Ghias, MD, FAAD, discusses Tono Health's role in improving access to skin care for patients of color, addressing systemic barriers and enhancing diagnostic accuracy.
Explore insights from SDPA leaders Renata Block, DMSc, MMS, PA-C, and Sarah Vicari, MMS, PA-C, on mentorship, volunteerism, and fostering growth for PAs.
At Elevate-Derm Fall, Ken Korber, PA-C, MHPE, DFAAPA, highlighted how literacy-aware communication and team-based collaboration can elevate patient understanding, adherence, and outcomes.
Kassandra Holzem, MD, shares vital insights on dermatology red flags and GVHD management, enhancing oncology care at SDPA Fall 2025.
Massimo Gadina, PhD, underscored the need for genetics-guided patient selection to improve treatment specificity in inflammatory skin diseases.
Kim explores the significance of inflammation in dermatology, revealing its connections to various diseases and the importance of focused research.
SDPA Emerging Scholars share insights on mentorship and professional growth, highlighting the importance of collaboration in dermatology.
Baldwin discusses the latest advancements in acne and rosacea treatments, including innovative therapies and promising clinical trials.
Heather Goff, MD, MPH, shares vital insights on lifestyle, ethics, and cutaneous lymphomas at SDPA Fall 2025, highlighting the future of dermatology.
Advances in atopic dermatitis research could bring longer-lasting biologics and improved treatment adherence.
Explore the latest insights on psoriatic arthritis and psoriasis management from Shikha Singla, MD, emphasizing multidisciplinary care and early screening strategies.
Kristine Kucera, PA-C, MPAS, DHS, reflects on her impactful 30-year career and celebrates the evolution of dermatology PAs at the SDPA Fall 2025 conference.
Discover how the SDPA Diplomate Fellowship has evolved with innovative learning tools, enhancing education for dermatology PAs at the Fall 2025 conference.
Lisa Weiss, MMSc, PA-C, and Justin Love, PA-C, discuss the importance of broad differentials, repeat biopsies, and national networking to strengthen diagnostic accuracy and provider support at Elevate-Derm Fall.
At Elevate-Derm 2025, Diego Ruiz Dasilva, MD, emphasized cross-role teamwork and urged clinicians to consider positive JAK inhibitor safety data.
Don’t miss a moment of Dermatology Times by signing up for our
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.